On Legalizing Medical Cannabis: The DEA Responds

A DEA official responded at length today to a widely-circulated report that the DEA plans to effectively legalize medical cannabis this August.

In an interview with aNewDomain today, DEA staff coordinator Russ Bear wouldn’t confirm the Santa Monica Observer report that the DEA will reschedule cannabis as a prescription-only Schedule II drug on Aug. 1, 2016. But he did comment at length about the agency’s thoughts around legalizing medical cannabis and how rescheduling cannabis from its current Schedule I status would have to work.

Bear, in his comments, went well beyond the prepared statement the agency gave to the The Houston Chronicle and other media covering the story earlier today. Check out his comments and our takeaway below.

“This is a complicated plant.” 

First off, the decision to reschedule cannabis isn’t a simple one because cannabis biochemistry is so complex, Bear said, and the variety of forms medical cannabis now takes are many.

“What is under-reported right now is...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.